0.8654
price down icon2.26%   -0.0155
 
loading
Xortx Therapeutics Inc stock is traded at $0.8654, with a volume of 31,460. It is down -2.26% in the last 24 hours and up +4.20% over the past month. XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
See More
Previous Close:
$0.8809
Open:
$0.8624
24h Volume:
31,460
Relative Volume:
0.51
Market Cap:
$4.48M
Revenue:
-
Net Income/Loss:
$-736.70K
P/E Ratio:
-86.54
EPS:
-0.01
Net Cash Flow:
$-4.14M
1W Performance:
-4.86%
1M Performance:
+4.20%
6M Performance:
+1.29%
1Y Performance:
-43.73%
1-Day Range:
Value
$0.85
$0.906
1-Week Range:
Value
$0.8272
$0.9936
52-Week Range:
Value
$0.6608
$2.51

Xortx Therapeutics Inc Stock (XRTX) Company Profile

Name
Name
Xortx Therapeutics Inc
Name
Phone
-
Name
Address
-
Name
Employee
3
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
XRTX's Discussions on Twitter

Compare XRTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
XRTX
Xortx Therapeutics Inc
0.86 4.59M 0 -736.70K -4.14M -0.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
406.99 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
472.31 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
551.43 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
809.14 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
330.74 35.16B 4.56B -176.77M 225.30M -1.7177

Xortx Therapeutics Inc Stock (XRTX) Latest News

pulisher
08:28 AM

Tools to assess XORTX Therapeutics Inc.’s risk profile2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - newser.com

08:28 AM
pulisher
05:41 AM

How to build a custom watchlist for XORTX Therapeutics Inc.Market Risk Report & Real-Time Buy Signal Alerts - newser.com

05:41 AM
pulisher
Oct 11, 2025

What analysts say about XORTX Therapeutics Inc stockFinancial Sector Performance & Low Risk Investment Portfolio - earlytimes.in

Oct 11, 2025
pulisher
Oct 10, 2025

Why XORTX Therapeutics Inc. is moving todayTake Profit & Reliable Price Action Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How institutional ownership impacts XORTX Therapeutics Inc. stock2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is a relief rally coming for XORTX Therapeutics Inc. holdersGold Moves & AI Driven Stock Movement Reports - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

XORTX Therapeutics Inc.’s volatility index tracking explainedTrade Ideas & Daily Price Action Insights - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will XORTX Therapeutics Inc. (ANUA) stock outperform energy sector in 2025Portfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Is XORTX Therapeutics Inc. a candidate for recovery play2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What analyst consensus implies for XORTX Therapeutics Inc. (ANUA) stockJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

XORTX Therapeutics Inc. stock trend outlook and recovery pathEarnings Performance Report & Reliable Breakout Forecasts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Will breakout in XORTX Therapeutics Inc. lead to full recovery2025 Investor Takeaways & Safe Entry Momentum Tips - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

How big funds are accumulating XORTX Therapeutics Inc. (ANUA) stockEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Comparing XORTX Therapeutics Inc. in custom built stock radarsJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Volatility clustering patterns for XORTX Therapeutics Inc.Bond Market & Community Shared Stock Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is XORTX Therapeutics Inc. (ANUA) stock attractive post correctionJuly 2025 Drop Watch & Reliable Price Breakout Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

What’s the recovery path for long term holders of XORTX Therapeutics Inc.Market Growth Summary & AI Driven Stock Price Forecasts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

How XORTX Therapeutics Inc. (ANUA) stock stacks up against competitors2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com

Oct 02, 2025
pulisher
Sep 29, 2025

What drives XORTX Therapeutics Inc ANUA stock priceEarnings Date Calendar & Big Gains Small Trading - earlytimes.in

Sep 29, 2025

Xortx Therapeutics Inc Stock (XRTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.60
price up icon 0.95%
$22.86
price up icon 6.98%
$32.48
price up icon 2.23%
$102.23
price up icon 0.32%
$165.94
price up icon 2.27%
biotechnology ONC
$330.74
price up icon 3.34%
Cap:     |  Volume (24h):